Supplementary Figure S2 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study

Supplementary Figure S2 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study

<p>Figure S2. Nomogram for predicting progression-free survival (PFS) based on t.TRPC and disease volume score.</p>

Spremljeno u:
Bibliografski detalji
Glavni autor: Ruiliang Wang (17333340) (author)
Daljnji autori: Jing Xu (22749676) (author), Chenyi Zhu (22749679) (author), Wujianhong Liu (22749682) (author), Chengqi Jin (22749685) (author), Wentao Luo (22749688) (author), Tingting Zhao (17333385) (author), Changcheng Guo (17333361) (author), Wei Chen (22749691) (author), Bin Yang (17333400) (author)
Izdano: 2025
Teme:
Cancer
Cancer Detection and Diagnosis
Methods and Technology
Biomarkers
Circulating tumor cells/DNA/exosomes
Genitourinary Cancers
Liquid Biopsy
Prostate Cancer
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Slični predmeti